Paper · 2001 · Biotechnology & Biotechnological Equipment

Full Resistance to Tobacco Mosaic Virus Infection Conferred by the Transgenic Expression of a Recombinant Antibody in Tobacco

K. Bajrovic; B. Erdag; E.O. Atalay; et al.

2
claims
4
verbatim quotes
17
citations
2
research areas
✓
Open access

Abstract

The objective of this study was to obtain transgenic tobacco (Nicotiana tabacum L. cv. Samsun NN) plants resistant to tobacco mosaic virus, TMV-vulgare strain, by the expression of a single-chain variable fragment (scFv-anti-TMV) against the TMV coat protein. The scFv-anti-TMV gene was made by combining the coding sequences of the heavy and light chain variable domains of the full antibody molecule with a sequence encoding a flexible linker. The scFv-anti-TMV was cloned under the control of the 35S promoter in the plant expression vector pBI121, and used for Agrobcterium-mediated transformation of tobacco. Integration of the scFv-anti-TMV gene into the genome of the transgenic plants and its expression were confirmed using PCR, immunoblot, and ELISA analysis. Transgenic plants expressing scFv-anti-TMV and untransformed control plants transformed with pBI121 only were inoculated with I μg/ml TMV. Constitutive expression of this scFv-anti-TMV resulted in complete immunity against TMV infection in transgenic plants (100% reduction of virus infection). In contrast, control plants were heavily infected by TMV. These results confirmed the applicability of antibody expression as a means of protecting plants from virus infection.

Abstract from the paper’s OpenAlex record, shown for indexing and research. Copyright remains with the authors or the publisher. Read at the source ↗

The text the model read, with the source record’s inline markup (italics, sub- and superscripts) rendered and its character entities decoded; quote offsets refer to the raw text.

Claims 2

Observationobservedoriginal resultmeasured

Claim · model-written summary

Integration and expression of scFv-anti-TMV were confirmed in transgenic tobacco.

Gene
scFv-anti-TMVe0
Outcome
Integration of the scFv-anti-TMV gene into the genome of the transgenic plants and its expressione0

Not reportedDirection

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Nicotiana tabacum
Nicotiana tabacum · TaxonJom / Joachim Müllerchen · CC BY 2.5 · Wikimedia Commons ↗

Verbatim

e0

“Integration of the scFv-anti-TMV gene into the genome of the transgenic plants and its expression were confirmed using PCR, immunoblot, and ELISA analysis.”

✓ located verbatim in the source · abstract, characters 614–769 · show in text ↑
t0

“in Tobacco”

✓ located verbatim in the source · title, characters 115–125 · show in text ↑
Intervention effectobservedoriginal resultpositivemeasured

Claim · model-written summary

Constitutive scFv-anti-TMV expression produced complete immunity to TMV infection, a 100% reduction relative to infected controls.

Treatment
Constitutive expression of this scFv-anti-TMVe0
Interactor
TMVTobacco mosaic viruse0pathogen
Gene
scFv-anti-TMVe0
Outcome
TMV infectione0
Direction
reductione0
Value
100%e0
Comparator
control plantse0

Organisms pictured · Representative pictures of the matched species, not figures from the paper.

Nicotiana tabacum
Nicotiana tabacum · TaxonJom / Joachim Müllerchen · CC BY 2.5 · Wikimedia Commons ↗
Tobacco mosaic virus
Tobacco mosaic virus · InteractorFrank Vincentz · CC BY-SA 3.0 · Wikimedia Commons ↗

Verbatim

e0

“Constitutive expression of this scFv-anti-TMV resulted in complete immunity against TMV infection in transgenic plants (100% reduction of virus infection). In contrast, control plants were heavily infected by TMV.”

✓ located verbatim in the source · abstract, characters 909–1122 · show in text ↑
t0

“in Tobacco”

✓ located verbatim in the source · title, characters 115–125 · show in text ↑

overexpression · Tobacco mosaic virus · Nicotiana tabacum (tobacco)Positive and negative results

4 papers: 2 positive, 2 negative or no effect

1 paper in the same direction as this paper · 2 in the opposite direction

  1. no effect
  2. negative
  3. positive
See all 4 papers →

Claims are grouped by organism, treatment and what was measured or targeted. A paper counts as positive when any of its claims in the group is positive.